BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 918406)

  • 1. [Antiarrhythmic effects and blood level of acebutolol as for oral administration (author's transl)].
    Suzuki M; Terukina M; Akamatsu T; Suzuki K
    Kokyu To Junkan; 1977 Sep; 25(9):813-22. PubMed ID: 918406
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic and antiarrythmic actions of acebutolol in clinical anesthesia (author's transl)].
    Yusa T; Matsukawa S; Shima T
    Masui; 1977 Dec; 26(13):1600-5. PubMed ID: 599649
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of cardiac arrhythmias with N-propyl-ajmalinium-hydrogentartrat (Neo-Gilurytmal (author's transl)].
    So CS; Oversohl K; Seidl KF
    Med Klin; 1974 May; 69(18):814-7. PubMed ID: 4134646
    [No Abstract]   [Full Text] [Related]  

  • 4. Acebutolol and oral surgery: plasma levels following a single oral dose.
    Fergusson NV; Dalgleish JG; Saunders DA
    Ann R Coll Surg Engl; 1985 Mar; 67(2):124-6. PubMed ID: 3883878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrophysiological properties of injectable acebutolol. A study of one case of auriculo-ventricular block observed under acebutolol per os (author's transl)].
    Clementy J; Clementy A; Roudaut R; Dallocchio D; Levy S; Bricaud H
    Ann Cardiol Angeiol (Paris); 1979; 28(4):261-8. PubMed ID: 507735
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correlations between plasmatic concentrations and antiarrhythmic effect of bunaphtine (author's transl)].
    Rossi P; Carcano G; Rognoni G; Cernigliaro C; Calcaterra G
    G Ital Cardiol; 1976; 6(6):1048-55. PubMed ID: 1022605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of taking lidocaine per os].
    Mironova KA; Ivanova EA; Galetskaia TM; Fomina AA; Spivak AM
    Vrach Delo; 1980 Dec; (12):45-8. PubMed ID: 7222579
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical--pharmacological problems of control--therapy with antiarrhythmic drugs (author's transl)].
    Mazur M; Wisławska-Orłowska B
    Przegl Lek; 1978; 35(9):735-7. PubMed ID: 715260
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial of a new antiarrhythmic agent and study of its blood levels].
    Desruelles J; Cuingnet E; Gérard A; Ducatillon P; Waucampt JJ
    Arch Mal Coeur Vaiss; 1968 Jun; 61(6):869-78. PubMed ID: 4175924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Basic problems of antiarrhythmic treatment (author's transl)].
    Follath F
    Schweiz Rundsch Med Prax; 1981 Sep; 70(37):1583-8. PubMed ID: 7053142
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of pirmenol on premature atrial complexes.
    Toivonen LK
    Ann Clin Res; 1986; 18(2):106-8. PubMed ID: 3521442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dose finding for clinical trials of antiarrhythmic substances (author's transl)].
    Hahn KJ
    Arzneimittelforschung; 1977 Feb; 27(2A):283-5. PubMed ID: 577177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiarrhythmic action of trimecaine in cardiac rhythm disorders].
    Orlov VM; Kruglov VA; Nikolaevskiĭ IR; Romanenko IA; Fedotenko SA
    Klin Med (Mosk); 1982 Jan; 60(1):57-9. PubMed ID: 7078041
    [No Abstract]   [Full Text] [Related]  

  • 14. Acebutolol metabolite plasma concentration during chronic oral therapy.
    Winkle RA; Meffin PJ; Ricks WB; Harrison DC
    Br J Clin Pharmacol; 1977 Oct; 4(5):519-22. PubMed ID: 911602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of oral pentisomide on ECG and hemodynamics].
    Ni Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Dec; 18(6):365-7. PubMed ID: 2093559
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention and treatment of drug-induced arrhythmia in acute myocardial infarct].
    Steffen V; Fiehring H
    Z Gesamte Inn Med; 1972 Oct; 27(20):875-81. PubMed ID: 4405247
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-arrhthmic effect of a new beta blocker in long term therapy of ambulatory patients].
    Dietz A; Walter J; Wiese K
    Med Welt; 1977 Nov; 28(44):1801-6. PubMed ID: 593120
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral antiarrhythmic agents for ventricular arrhythmias.
    Meissner MD; Nestico PF; Morganroth J
    Clin Ther; 1986; 8(6):595-604. PubMed ID: 3539346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of serum drug level monitoring during therapy with class III antiarrhythmic agents.
    Follath F
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S41-3. PubMed ID: 1279308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophysiologic effects of intravenous cibenzoline succinate, a new class I antiarrhythmic agent].
    Atarashi H; Iida K; Kou M; Hirayama Y; Gotoh M; Ino T; Katoh T; Hayakawa H
    Kokyu To Junkan; 1988 Oct; 36(10):1119-24. PubMed ID: 3247527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.